The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Quality of life after high-dose rate brachytherapy monotherapy for prostate cancer.
Jessika Contreras
No relevant relationships to disclose
Richard Wilder
No relevant relationships to disclose
Eric Albert Mellon
No relevant relationships to disclose
Tobin Joel Crill Strom
No relevant relationships to disclose
Daniel Celestino Fernandez
No relevant relationships to disclose
Matthew C. Biagioli
No relevant relationships to disclose